CORE
🇺🇦Â
 make metadata, not war
Services
Services overview
Explore all CORE services
Access to raw data
API
Dataset
FastSync
Content discovery
Recommender
Discovery
OAI identifiers
OAI Resolver
Managing content
Dashboard
Bespoke contracts
Consultancy services
Support us
Support us
Membership
Sponsorship
Community governance
Advisory Board
Board of supporters
Research network
About
About us
Our mission
Team
Blog
FAQs
Contact us
Filters
1 research outputs found
Hypofractionated radiotherapy with simultaneous integrated boost (SIB) plus temozolomide in good prognosis patients with glioblastoma: a multicenter phase II study by the Brain Study Group of the Italian Association of Radiation Oncology (AIRO)
Author
Alba Fiorentino
AWM Lee
+52Â more
B Jeremic
BD Killory
Beatrice Detti
C Chen
C Phillips
CA Perez
CB Scott
DA Larson
Daniela Doino
Daniela Greto
DE Ney
DR Macdonald
EHM Seegenschmiedt
EL Chang
Federico Lonardi
Fernanda Migliaccio
Giovanni Rubino
GL Jiang
JA Carlson
JD Cox
JJ McAleese
K Nakamatsu
K Sultanem
KH Cho
L Kleinberg
L Liu
Laura Masini
Livia Marrazzo
Lorenzo Livi
Luigi Pirtoli
M Massaccesi
M Suzuki
Marco Krengli
MC Hulshof
Michela Buglione
NS Floyd
R Ove
R Stupp
R Stupp
Riccardo Santoni
S Dische
S Shin
Salvino Marzano
Silvia Scoccianti
SM Yoon
Stefano Maria Magrini
T Iuchi
Umberto Ricardi
V Panet-Raymond
Vincenzo Fusco
W Budach
W Roa
Publication venue
'Springer Science and Business Media LLC'
Publication date
Field of study
No full text
Crossref